FSD Pharma Inc. filed a 6-K report on March 29, 2024, indicating compliance with SEC rules; the document includes signatures from management, confirming their ongoing regulatory obligations.
AI Assistant
QUANTUM BIOPHARMA LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.